Back to overview

Functional analysis of peroxisome proliferator-activated recep- tors by trans-dominant inhibition

Applicant Keller Hansjörg
Number 40590
Funding scheme Project funding
Research institution Novartis Pharma AG Arthritis & Bone Metabolism
Institution of higher education University of Lausanne - LA
Main discipline Molecular Biology
Start/End 01.10.1994 - 30.09.1996
Approved amount 110'400.00
Show all

Responsible applicant and co-applicants